Search clinical trials for: Placebo plus everolimus

Total 58595 results

Restorbio Inc.

Active, not recruiting

Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

Respiratory Tract Infections

United States
Samsung Medical Center

Completed

Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

Korea, Republic of
National Taiwan University Hospital
Novartis

Unknown

ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments

Metastatic Breast Cancer

Taiwan
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Active, not recruiting

Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs (MetNET1)

Well Differentiated Pancreatic Endocrine Tumor

Italy
Seung-Jung Park
Abbott Medical Devices; CardioVascular Research Foundation, Korea

Terminated

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST) (BEST)

Coronary Artery Disease

Thailand, Korea, Republic of, China, Malaysia
German Breast Group
Novartis

Terminated

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane (Evelyn)

Metastatic Breast Cancer

Germany
Novartis Pharmaceuticals

Completed

A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor (OSAT)

Metastatic Renal Cell Carcinoma (mRCC)

Norway
Novartis Pharmaceuticals

Completed

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Japan
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC (TRACER)

Hepatocellular Carcinoma

Hong Kong, Taiwan, Thailand
Shanghai University of Traditional Chinese Medicine
Fudan University; Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Chest... and other collaborators

Not yet recruiting

Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Lung Cancer

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (EXIST-2)

Lymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)

United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain
University of Bologna

Unknown

Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy (PROTECT)

Heart Transplantation | Cytomegalovirus Infection | Cardiac Allograft Vasculopathy

Italy
University Hospital, Bordeaux

Completed

Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors (EVAX)

Carcinoma, Renal Cell | Malignant Advanced Solid Tumors

France
GlaxoSmithKline

Completed

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects (Cancer)

Cancer

United States, France
Cardiff University
Novartis

Unknown

A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis (TRON)

Tuberous Sclerosis

United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors (RADIANT-3)

Advanced Neuroendocrine Tumors of Pancreatic Origin

Canada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
University of Chicago
Novartis Pharmaceuticals

Terminated

Everolimus Versus Placebo in Head and Neck Cancer

Head and Neck Cancer

United States
Eisai Co., Ltd.

Completed

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

Japan
Novartis Pharmaceuticals

Completed

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy (PILLAR2)

Diffuse Large B-cell Lymphoma

China, United States, Colombia, Turkey, Spain, Egypt, Canada, Italy, Singapore, Australia, Austria, Czechia, Greece, Israel, Russian Federation, Hong Kong, Thailand, Korea, Republic of, Lebanon, Japan, Poland, Slovakia, Switzerland, G... and more
Sidney Kimmel Comprehensive Cancer Center at Johns...
Greater Washington Community Foundation

Terminated

Muscadine Plus (MPX) In Men With Prostate Cancer

Adenocarcinoma of the Prostate

United States
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Chemotherapy-Induced Thrombocytopenia
Heilongjiang University of Chinese Medicine

Recruiting

Chinese Herbal Medicine and Micronized Progesterone for Live Births in Threatened Miscarriage

Threatened Miscarriage

China
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Completed

Synergic Effects of Ultrasound and Laser on the Pain Relief and Functionality

Osteoarthritis

Brazil
University of Memphis

Completed

Impact of JuicePlus+ on the Health Status of an Overweight Stressed Population

Inflammation

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) (GRANITE-1)

Advanced Gastric Cancer

China, United States, Belgium, France, Taiwan, United Kingdom, Canada, Spain, Italy, Australia, Russian Federation, Thailand, Korea, Republic of, Israel, Germany, Peru, Argentina, Japan, Hong Kong, New Zealand, Mexico, Netherlands
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

Uroial Plus in the Management of Infections and Urinary Symptoms Associated With Ureteral Stents (USSIAL)

Urinary Tract Infections | Ureteral Stent-Related Symptom
Government Dental College and Research Institute...

Completed

Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis

Chronic Periodontitis

India
Hospital Clínico Universitario de Valladolid

Unknown

Salt Intake, Microbiota, Immune Response and Endothelial Function in Hypertension

Hypertension

Spain
Massachusetts General Hospital
Vedanta Biosciences, Inc.

Recruiting

VE416 for Treatment of Food Allergy

Peanut Allergy

United States
China National Center for Cardiovascular Diseases
Fuwai Hospital, Chinese Academy of Medial Sciences, Shenzhen, Shenzhen

Recruiting

Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease (FUTURE)

Hypertension | Diabetes | Hypercholesterolemia

China
Birmingham Community Healthcare NHS
NSA, LLC

Completed

Effect of Dietary Intake of Dried Whole Food Concentrates (Juice Plus) on Clinical Outcomes Following Periodontal Therapy: A Pilot Study (BHAM-NSA-05-01)

Periodontitis

United Kingdom
Edesa Biotech Inc.
JSS Medical Research Inc.

Recruiting

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19

COVID-19 | ARDS

United States, Canada
Giellepi S.p.A
Opera CRO, a TIGERMED Group Company

Completed

Clinical Trial to Assess the Efficacy of µSmin® Plus

Chronic Venous Disease

Romania
LG Life Sciences

Completed

Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

Osteoarthritis of the Knee

Korea, Republic of
Guang'anmen Hospital of China Academy of Chinese...
Beijing Anzhen Hospital

Completed

Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

Coronary Heart Disease

China
Calithera Biosciences, Inc

Completed

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) (ENTRATA)

Clear Cell Renal Cell Carcinoma

United States
China Medical University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia

Schizophrenia

Taiwan
Henan University of Traditional Chinese Medicine

Recruiting

Effects of Traditional Chinese Medicine on Outcomes in Patients With AECOPD Risk Window

Chronic Obstructive Pulmonary Disease

China
Huashan Hospital
Jiangsu HengRui Medicine Co., Ltd.; Shanghai Sunstem Biotechnology Co., Ltd.

Recruiting

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Recurrent Glioblastoma

China
Miguel Blanca Gomez

Completed

Subcutaneous Immunotherapy With Dermatophagoides Pteronyssinus in Local Allergic Rhinitis (ECRL1)

Local Allergic Rhinitis

Spain
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

China
Timothy Welty, PharmD

Unknown

Catamenial Epilepsy Treatment

Epilepsy

United States
Tang-Du Hospital
Zhejiang University; Chipscreen Biosciences, Ltd.; First Affiliated Hospital...

Unknown

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Chronic HIV Infections

China
China National Center for Cardiovascular Diseases

Not yet recruiting

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals With Obesity and NAFLD (BRAVO)

Obesity | NAFLD | Obesity, Abdominal

China
Beijing 302 Hospital

Completed

Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis

Liver Cirrhosis

China
Beijing 302 Hospital

Unknown

Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
Birmingham Community Healthcare NHS
University of Wuerzburg; Academic Centre for Dentistry in Amsterdam

Completed

The Effect of Daily Dietary Intake of Dried Juice Concentrates of Fruit, Vegetables and Berries Upon Outcomes of Chronic Periodontitis (ENURGISE)

Periodontitis

Germany, Netherlands, United Kingdom
China Medical University Hospital
National Health Research Institutes, Taiwan

Recruiting

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Schizophrenia

Taiwan
China Medical University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

Schizophrenia

Taiwan

Search clinical trials for: Placebo plus everolimus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations